Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Inflammasome Therapeutics

Clinical trials sponsored by Inflammasome Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New ALS drug trial aims to tame inflammation Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1 Completed 1

New eye drug shows promise for blinding disease

Disease control Completed

This early-stage trial tests an experimental drug called Kamuvudine-8 (K8) for people with geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. About 30 participants receive eye injections of K8 and are monitored for 26 weeks to check s…

Phase 1/2 • Sponsor: Inflammasome Therapeutics • Aim: Disease control

Last updated Jul 22, 2026 00:00 UTC